It exerts its oncogenic effects primarily by binding to its receptor, Nucleolin (NCL), through which it modulates various signaling pathways critical for the regulation of tumor progression and the maintenance of the TME (15, 16). Here, NUCLEOLIN is linked to neoplasm.